Caitlin Kontulis - 15 Feb 2024 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Secretary & VP Finance & Admin
Signature
/s/ Caitlin Kontulis
Issuer symbol
PHIO
Transactions as of
15 Feb 2024
Transactions value $
-$773
Form type
4
Filing time
20 Feb 2024, 19:03:51 UTC
Previous filing
03 Mar 2023
Next filing
05 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Tax liability -$428 -658 -5.41% $0.65 11.5K 15 Feb 2024 Direct F1, F2
transaction PHIO Common stock, $0.0001 par value Tax liability -$345 -523 -4.55% $0.66 11K 17 Feb 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.
F2 Includes shares of common stock underlying unvested restricted stock units.